BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 35926751)

  • 1. Immediate release 3D printed oral dosage forms: How different polymers have been explored to reach suitable drug release behaviour.
    Funk NL; Fantaus S; Beck RCR
    Int J Pharm; 2022 Sep; 625():122066. PubMed ID: 35926751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
    Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
    Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
    Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
    Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
    Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
    J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis-Personalized Dosing and Drug Release.
    Öblom H; Zhang J; Pimparade M; Speer I; Preis M; Repka M; Sandler N
    AAPS PharmSciTech; 2019 Jan; 20(2):52. PubMed ID: 30617660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation into the effects of geometric scaling and pore structure on drug dose and release of 3D printed solid dosage forms.
    McDonagh T; Belton P; Qi S
    Eur J Pharm Biopharm; 2022 Aug; 177():113-125. PubMed ID: 35779743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical review of traditional and advanced characterisation tools to drive formulators towards the rational development of 3D printed oral dosage forms.
    Deon M; Dos Santos J; de Andrade DF; Beck RCR
    Int J Pharm; 2022 Nov; 628():122293. PubMed ID: 36252640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D printed oral solid dosage form: Modified release and improved solubility.
    Wang N; Shi H; Yang S
    J Control Release; 2022 Nov; 351():407-431. PubMed ID: 36122897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery.
    Gioumouxouzis CI; Baklavaridis A; Katsamenis OL; Markopoulou CK; Bouropoulos N; Tzetzis D; Fatouros DG
    Eur J Pharm Sci; 2018 Jul; 120():40-52. PubMed ID: 29678613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct Granule Feeding of Thermal Droplet Deposition 3D Printing of Porous Pharmaceutical Solid Dosage Forms Free of Plasticisers.
    McDonagh T; Belton P; Qi S
    Pharm Res; 2022 Mar; 39(3):599-610. PubMed ID: 35194719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D printing hybrid materials using fused deposition modelling for solid oral dosage forms.
    Krueger L; Miles JA; Popat A
    J Control Release; 2022 Nov; 351():444-455. PubMed ID: 36184971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supramolecular chemistry enables vat photopolymerization 3D printing of novel water-soluble tablets.
    Ong JJ; Chow YL; Gaisford S; Cook MT; Swift T; Telford R; Rimmer S; Qin Y; Mai Y; Goyanes A; Basit AW
    Int J Pharm; 2023 Aug; 643():123286. PubMed ID: 37532009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Geometry on the Drug Release Profiles of Stereolithographic (SLA) 3D-Printed Tablets.
    Martinez PR; Goyanes A; Basit AW; Gaisford S
    AAPS PharmSciTech; 2018 Nov; 19(8):3355-3361. PubMed ID: 29948979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing.
    Goyanes A; Fina F; Martorana A; Sedough D; Gaisford S; Basit AW
    Int J Pharm; 2017 Jul; 527(1-2):21-30. PubMed ID: 28502898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of porosity on drug release kinetics of swellable and erodible porous pharmaceutical solid dosage forms fabricated by hot melt droplet deposition 3D printing.
    Zhang B; Nasereddin J; McDonagh T; von Zeppelin D; Gleadall A; Alqahtani F; Bibb R; Belton P; Qi S
    Int J Pharm; 2021 Jul; 604():120626. PubMed ID: 33957266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation into the effects of ink formulations of semi-solid extrusion 3D printing on the performance of printed solid dosage forms.
    Zhang B; Belton P; Teoh XY; Gleadall A; Bibb R; Qi S
    J Mater Chem B; 2023 Dec; 12(1):131-144. PubMed ID: 38050731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D screen printing technology enables fabrication of oral drug dosage forms with freely tailorable release profiles.
    Enke M; Schwarz N; Gruschwitz F; Winkler D; Hanf F; Jescheck L; Seyferth S; Fischer D; Schneeberger A
    Int J Pharm; 2023 Jul; 642():123101. PubMed ID: 37295568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabricating 3D printed orally disintegrating printlets using selective laser sintering.
    Fina F; Madla CM; Goyanes A; Zhang J; Gaisford S; Basit AW
    Int J Pharm; 2018 Apr; 541(1-2):101-107. PubMed ID: 29454028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective laser sintering additive manufacturing of dosage forms: Effect of powder formulation and process parameters on the physical properties of printed tablets.
    Tikhomirov E; Åhlén M; Di Gallo N; Strømme M; Kipping T; Quodbach J; Lindh J
    Int J Pharm; 2023 Mar; 635():122780. PubMed ID: 36849041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.